Pneumonia

See highlights of CDC 2023 immunization updates for: pneumococcal disease; measles, mumps, and rubella; hepatitis B; polio; and monkeypox.

Get a quick topline look at specific revisions and additions included in the ACIP's recommendations for routine immunization of those aged ≥19 years in the US.

How much do you know about diphtheria and the vaccine? Answer these 2 questions to find out.

SAMPLE: A 7-year-old child newly immigrated to the US has not received any previous pneumococcal vaccines. What does the CDC recommend for this child?

How much do you know about the latest adult pneumococcal vaccine recommendations from the ACIP? Try your hand at these 4 questions to find out.

Low rates of routine adult vaccination, reduced further during the 2020-21 pandemic months, threaten a surge in these conditions as the US reopens, says the National Adult and Influenza Immunization Summit.

The American College of Physicians urges clinicians to make sure adult patients, especially the most vulnerable, are protected against preventable diseases as COVID spreads and flu is imminent.

Rates of routine ACIP-recommended vaccination have been persistently and significantly lower among racial and ethnic minorities over the past decade, according to new research.

From obesity to pneumococcal disease, we have picked the top 6 FDA-approved drugs every primary care physician should know about from the second quarter.

The vaccine is indicated for prevention of invasive disease and pneumonia caused by 20 Streptococcus pneumoniae serotypes.

Longer antibiotic treatment courses can often be safely and effectively shortened, according to the ACP guidance; 4 common conditions serve as examples.

Routine adult vaccination rates have yet to reach pre-pandemic levels, according to a report in MMWR this week. Which vaccines are most affected and which groups are lagging?

Review changes to the CDC Advisory Committee on Immunization Practices' 2021 recommended vaccination schedule for adults with this short slide-show review.

A new survey from the National Foundation for Infectious Diseases found key insights into what Americans believe about flu, pneumococcal disease, and COVID-19.

Once again, the USPSTF finds no net benefit to screening asymptomatic persons for COPD. Draft recommendation is available for comment.

Reductions in mortality, need for life support, hospital stays, and other measures should win this drug class serious consideration, study authors say.

Targeting these risk factors with adjunctive therapy may help improve outcomes, say authors of a new study.

A new CDC study also found that older adults are more likely to be hospitalized for a severe respiratory virus than those aged 18 to 49 years.

Infections with pneumonia send a substantial number of older adults to the hospital, much more than younger adults. Researchers are calling for new rapid diagnostic tests.

Proposed mechanisms for the association include PPI-induced acute pH dysregulation and alteration of the gut microbiome.

The price tag for an ICU stay was more than 5 times higher for pneumonia patients. Can we find an ounce of prevention?

Undiagnosed lung disease in smokers, the impact of guidelines for community-acquired pneumonia in children, and climate change and asthma attacks make headlines in the respiratory news.

Thirty minutes/day of hospital-based physical therapy reduced 30-day readmission, an important Medicare hospital performance metric.

The combined measures may help reduce hospitalizations by reclassifying CAP patients at low risk for adverse events.

Respiratory disease is the main reason why patients visit primary care practices. This brief summary highlights the latest in research and patient care.

This slideshow highlights facts and figures about the number 1 diagnostic category in primary care.

Three studies culled from the very recent literature offer insights into prevention and treatment of pneumonia in adults. Highlights in this slide show.

The 13-valent pneumococcal conjugate vaccine reduced nearly by half vaccine-type community acquired pneumonia in adults aged 65 years and older.

Risk of MI, stroke, and fatal coronary heart disease remained elevated among some patients hospitalized for pneumonia up to 10 years after the index event.

Several related health concerns-including asthma, pericarditis, and pneumonia-are treatable within the primary care office.